Cencora (COR) ROIC: History & Chart

Cencora, Inc. (COR)CORCencora, Inc.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA

51,000 employees

www.cencora.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Robert Mauch

View full financials

COR Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

13.23%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

15.09%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

14.58%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

13.58%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

11.78%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

14.65%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

13.65%

CURRENT VS TTM AVG

-12.30%

CURRENT VS 3Y AVG

-9.27%

CURRENT VS 5Y AVG

-2.57%

CURRENT VS 10Y AVG

+12.28%

CURRENT VS 15Y AVG

-9.72%

CURRENT VS 20Y AVG

-3.09%

SECTOR MEDIAN · HEALTHCARE

8.53%

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

+55.10%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Cencora, Inc. (COR)	$62.18B	13.23%	15.09%	14.58%	13.58%
Becton, Dickinson and Company (BDX)vs ›	$60.26B	4.73%	4.38%	4.32%	3.88%
Boston Scientific Corporation (BSX)vs ›	$68.46B	8.78%	7.46%	6.12%	5.55%
Cardinal Health, Inc. (CAH)vs ›	$54.46B	11.37%	10.09%	4.86%	-0.22%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$71.62B	8.51%	9.70%	12.91%	18.22%
Edwards Lifesciences Corporation (EW)vs ›	$48.18B	11.40%	11.07%	14.43%	15.83%
Humana Inc. (HUM)vs ›	$46.67B	3.12%	3.25%	5.37%	7.01%
IDEXX Laboratories, Inc. (IDXX)vs ›	$44.93B	40.27%	37.07%	34.89%	35.94%
Cigna Corporation (CI)vs ›	$79.64B	7.35%	7.02%	7.07%	6.50%
Elevance Health Inc. (ELV)vs ›	$83.65B	6.65%	6.70%	7.11%	7.33%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Cencora, Inc. (COR)

$62.18B

13.23%

15.09%

14.58%

13.58%

Becton, Dickinson and Company (BDX)vs ›

$60.26B

4.73%

4.38%

4.32%

3.88%

Boston Scientific Corporation (BSX)vs ›

$68.46B

8.78%

7.46%

6.12%

5.55%

Cardinal Health, Inc. (CAH)vs ›

$54.46B

11.37%

10.09%

4.86%

-0.22%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$71.62B

8.51%

9.70%

12.91%

18.22%

Edwards Lifesciences Corporation (EW)vs ›

$48.18B

11.40%

11.07%

14.43%

15.83%

Humana Inc. (HUM)vs ›

$46.67B

3.12%

3.25%

5.37%

7.01%

IDEXX Laboratories, Inc. (IDXX)vs ›

$44.93B

40.27%

37.07%

34.89%

35.94%

Cigna Corporation (CI)vs ›

$79.64B

7.35%

7.02%

7.07%

6.50%

Elevance Health Inc. (ELV)vs ›

$83.65B

6.65%

6.70%

7.11%

7.33%

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Cencora, Inc. (COR)?

The return on invested capital (ROIC) for COR stock is 13.23%.

Is Cencora, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 13.23% is in line with its 5-year average of 13.58%, around the middle of its 5-year range (11.30%–16.94%).

What is the TTM average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The TTM average return on invested capital (ROIC) for COR stock is 15.09%.

What is the 3Y average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The 3Y average return on invested capital (ROIC) for COR stock is 14.58%.

What is the 5Y average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The 5Y average return on invested capital (ROIC) for COR stock is 13.58%.

What is the 10Y average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The 10Y average return on invested capital (ROIC) for COR stock is 11.78%.

What is the 15Y average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The 15Y average return on invested capital (ROIC) for COR stock is 14.65%.

What is the 20Y average return on invested capital (ROIC) for Cencora, Inc. (COR)?

The 20Y average return on invested capital (ROIC) for COR stock is 13.65%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2025-09-30	13.23%
2024-09-30	16.94%
2023-09-30	13.48%
2022-09-30	14.68%
2021-09-30	11.30%
2020-09-30	11.84%
2019-09-30	16.94%
2018-09-30	16.59%
2017-09-30	9.36%
2016-09-30	18.77%
2015-09-30	-13.52%
2014-09-30	11.68%
2013-09-30	14.62%
2012-09-30	18.48%
2011-09-30	17.02%
2010-09-30	14.89%
2009-09-30	13.64%
2008-09-30	12.52%
2007-09-30	11.11%
2006-09-30	8.64%
2005-09-30	7.30%
2004-09-30	9.27%
2003-09-30	9.18%
2002-09-30	8.37%
2001-09-30	3.36%
2000-09-30	17.57%
1999-09-30	14.09%
1998-09-30	17.21%
1997-09-30	11.82%
1996-09-30	16.76%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2025-09-30

13.23%

2024-09-30

16.94%

2023-09-30

13.48%

2022-09-30

14.68%

2021-09-30

11.30%

2020-09-30

11.84%

2019-09-30

16.94%

2018-09-30

16.59%

2017-09-30

9.36%

2016-09-30

18.77%

2015-09-30

-13.52%

2014-09-30

11.68%

2013-09-30

14.62%

2012-09-30

18.48%

2011-09-30

17.02%

2010-09-30

14.89%

2009-09-30

13.64%

2008-09-30

12.52%

2007-09-30

11.11%

2006-09-30

8.64%

2005-09-30

7.30%

2004-09-30

9.27%

2003-09-30

9.18%

2002-09-30

8.37%

2001-09-30

3.36%

2000-09-30

17.57%

1999-09-30

14.09%

1998-09-30

17.21%

1997-09-30

11.82%

1996-09-30

16.76%

Return on Invested Capital (ROIC): 13.23%

COR Return on Invested Capital (ROIC) Chart

COR Average Return on Invested Capital (ROIC) Chart

COR Current vs Average Return on Invested Capital (ROIC) Chart

COR Return on Invested Capital (ROIC) Metrics

COR Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

COR Return on Invested Capital (ROIC) History

Related Metrics